0
1652
Actos Multidistrict Litigation Pending As EMA And FDA Still Pushing Drug As Second Line Treatment
The European Medicines Agency has recently announced that, despite a serious risk for causing bladder cancer, the prescription medication Actos – or Glustin as it is known in some European countries – should still be prescribed by physicians as a... Read more






